For a CEO who led the company for seven years, Mohit Malhotra’s exit from FMCG major Dabur India was silent. Unlike other recent CEO exits, such as Sudhir Sitapati’s from Godrej Consumer Products or Rohit Jawa’s from Hindustan Unilever (HUL).
The Street’s muted reaction to Malhotra’s resignation as global CEO of Dabur India can perhaps be attributed to the company’s lacklustre performance over the last few years.
“The company has not fared greatly under Malhotra and his exit is being seen as an indication that the company is trying to push the pedal on growth,” an analyst with a top brokerage firm told The Financial Standard.
The CEO’s exit, analysts indicate, is part of the company’s strategy to emerge out of its growth slump. Earlier in April, the company had roped in Herjit Singh Bhalla as the CEO while elevating Malhotra to the global CEO role.
Bhalla has worked with FMCG majors such as The Hershey Company, METRO Cash and Carry India, and HUL before joining Dabur.
The company later changed the reporting structure of a few top executives and realigned its senior management structure. It brought key business heads, including those overseeing sales, healthcare, and home and personal care, under Bhalla.
The company is now investing in reviving its core, premiumising its portfolio, and improving efficiency.
“We want to accelerate growth; that's very clear. That is something that this business needs to be doing, and has the right to do so. We want to further enhance our execution. We want to build a future-ready portfolio,” Bhalla said while addressing investors at the company’s second-quarter earnings call.
"We need to find the money to invest behind all of this," he added.
The company is increasing its advertising and media spend to push its core portfolio of brands such as Chyawanprash, Dabur Honey, and Dabur Red Toothpaste.
For instance, there are plans to introduce Chyawanprash in new formats like gummies. The company is also working to improve its distribution; it has introduced a 'Retail Next' programme and is scaling it across 40,000 stores. Dabur has set a target of growing sales in these outlets at 1.5 times the rate of the rest of general trade.
Bhalla said the company also wants to tap the premiumisation trend. “Premium products' share of Dabur's portfolio has increased from 17% to 20% over the preceding 18 months. We want to enhance further and take our premiumisation up to 23% over the next 18 months,” he said.
Analysts, however, feel that the recent commentary does not indicate that Dabur is looking at an overhaul of its portfolio.
“It does not seem from recent management commentary that they are pursuing a more disruptive approach. They have, however, not shied away from new category forays (such as coconut hair oils, health juices, cold-pressed edible oils) or from acquisitions, as they have a ₹500 crore Dabur Ventures fund to scout for opportunities,” said Abhishek Mathur, CFA, lead analyst, India Institutional Equity Research at Systematix Group.
The renewed push comes after a subdued performance by the company post-Covid. Dabur India’s revenue grew just 1% on a two-year CAGR basis from the financial year 2024-26, according to a report by HDFC Securities. The company’s sales volumes, too, during the period inched up only 2%.
Meanwhile, its competitors such as Marico and Godrej Consumer Products reported 8% and 6% growth in sales volumes during this period, respectively.
The abysmal performance was led by a slowdown in its core portfolio, which includes some marquee names such as Dabur Chyawanprash, Dabur Honey, and Real juices. Dabur’s health portfolio, which includes Chawayanprash, grew just 0.2% in FY26, while its food and beverages portfolio that houses Real juices declined 1.7%.
“Their edge in Ayurveda has diluted over the years as the consumer preference for these products has changed,” said the analyst quoted above.
“Beverages segment growth has also been low, likely impacted by competitive aggression from Reliance’s Campa over the last two years, with consumers looking for affordable hydration appearing to favour Campa over the more premium nectars,” said Mathur.
The company has also suffered from the emergence of D2C brands and quick commerce as a channel, as it was slow to tap these new trends and, as a result, its general trade network too came under pressure.
All eyes are now on Bhalla to bring the growth back for Dabur.
Although on a low base, Dabur’s performance in the last two quarters since Bhalla took over has improved. In Q1 FY27, the company’s revenue grew 11% year-on-year to ₹3,764 crore, supported by 5% domestic volume growth. In Q2, the company’s revenue growth climbed 11.6% to ₹3,563 crore, while volume jumped 5.5%.
Bhalla’s real test, much like the larger FMCG industry's, is grappling with inflation, which threatens to impact margins.
“The new CEO is expected to mainly reignite growth in the subdued categories and also leverage Dabur’s legacy strength in certain categories of health and wellness,” said Mathur.